Bio-Connect
Human CXCL11/I-TAC PicoKine ELISA Kit standard curve
Human CXCL11/I-TAC PicoKine ELISA Kit standard curve
Human CXCL11/I-TAC PicoKine ELISA Kit standard curve

Human CXCL11/I-TAC PicoKine ELISA Kit

EK0737
Boster Bio
ReactivityHuman
Product group Assays
96 wells
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    Boster Bio
  • Product Name
    Human CXCL11/I-TAC PicoKine ELISA Kit
  • Delivery Days Customer
    9
  • Applications
    ELISA
  • Applications Supplier
    ELI
  • Assay Detection Range
    31.2 pg/ml - 2,000 pg/ml
  • Assay Sensitivity
    <10 pg/ml
  • Assay Time
    15-20
  • Certification
    Research Use Only
  • Scientific Description
    Human CXCL11/I-TAC ELISA Kit PicoKine® (96 Tests). Quantitate Human CXCL11 in cell culture supernatants, cell lysates, serum and plasma (heparin, EDTA). Sensitivity: 10pg/ml. The brand Picokine indicates this is a premium quality ELISA kit. Each Picokine kit delivers precise quantification, high sensitivity, and excellent reproducibility. Only our most reliable and effective kits qualify as Picokine, guaranteeing top-tier results for your assays.
  • Reactivity
    Human
  • Reactivity Supplier
    Human CXCL11
  • Storage Instruction
    -20°C,2°C to 8°C
  • UNSPSC
    41116158

References

  • Lv Y, Yang Z, Hai L, et al. Differential alterations of CXCR3, CXCR5 and CX3CR1 in patients with immune thrombocytopenia. Cytokine. 2024,181:156684. doi: 10.1016/j.cyto.2024.156684
    Read this paper
  • Cai X, Yu X, Tang T, et al. JMJD2A promotes the development of castration-resistant prostate cancer by activating androgen receptor enhancer and inhibiting the cGAS-STING pathway. Mol Carcinog. 2024,63(9):1682-1696. doi: 10.1002/mc.23753
    Read this paper
  • Lu Y, Lin LY, Tan JG, et al. A correlation study between gene polymorphism of Th cell expressed chemokine receptor CXCR3 and its ligand levels with HCV infection prognosis. Eur Rev Med Pharmacol Sci. 2017,21(6):1290-1295.
    Read this paper